Company Directory / research

Accent Therapeutics logo

PrivateFor profitresearchLexington, United States

Accent Therapeutics

Accent Therapeutics is a biopharmaceutical company.

Founded
2017
9 years ago
Staff
11-50
band, as listed
Followers
-
on LinkedIn
Funding
$178M
as listed, currency not stated

Set against six million companies

Size

1-1011-5051-100101-250251-500501-10001k-5k5k-10k10k+

11-50 people: larger than 33% of companies with a size listed

Age

201719002026

9 years old.

Reach

Website ranked #3,906,068 in the world for traffic, about 3k visits a month.

What it does

BiotechnologyMedicalPharmaceuticalTherapeutics

Funding, as listed

$178M currency not stated

  • Rounds3
  • LatestSeries c, Jan 2024
  • Investors13, 3 leading

What the source datasets report. We have not watched these rounds ourselves.

FoundersRobert A. Copeland

Every detail we hold

Everything the source datasets list about Accent Therapeutics, field by field. Contact details are held but never shown.

The company

Name
Accent Therapeutics
Type
For profit
Status
Private
Founded
2017
Founders
Robert A. Copeland
Industry
research
Categories
Biotechnology, Medical, Pharmaceutical, Therapeutics

Where

City
Lexington
Country
United States
Markets
Greater Boston Area, East Coast, New England, Northeastern US

Size and reach

Staff band
11-50
Web traffic rank
#3,906,068
Monthly web visits
2,902

Funding, as listed

Total
178,000,000 (currency not stated)
Rounds
3
Latest round
Series c
Latest round date
Jan 2024
Investors
13
Lead investors
3
Listing status
private

About this record

Sources
Crunchbase
Last imported
Sept 2026

Growth, as the source summarises it

Accent Therapeutics may be growing as evidenced by the presentation of data supporting two lead programs at the AACR 2024 Annual Meeting, which suggests progress in their research and development efforts. The company's active participation in significant industry conferences indicates ongoing projects and potential advancements in their pipeline. Furthermore, the focus on lead programs implies a strategic approach to their product development, which can be a positive sign for growth within the biopharmaceutical sector.

Summaries written by the source dataset, not by us, and not checked.

Companies like it

research in United States.

See all in the directory →

From the company datasets we hold (Crunchbase, LinkedIn and Apollo listings), as listed there; 1,637,054 companies in United States and 5,926,251 in all. We hold no contact details for public display. Correct this, or ask for it to be removed.